IN THE NEWS - SMURF-Therapeutics, Inc.

Skip to content Skip to footer

Close

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation: Molecular Cell

February 4, 20240Comments

Go to Top